Related Experiment Video
Updated: Jun 25, 2025

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Sonodynamic therapy for the treatment of atherosclerosis
Yan Zhang1, Ying Yang2, Yudi Feng1
1The Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Sonodynamic therapy (SDT) shows promise for treating atherosclerosis (AS) by inhibiting plaque progression and stabilizing arterial inflammation. This review details SDT
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Oncology
Background:
- Atherosclerosis (AS) is a chronic inflammatory arterial disease with high mortality and disability rates despite current treatments.
- Sonodynamic therapy (SDT) emerges as a promising non-invasive therapeutic approach for AS.
- SDT offers localized treatment for inhibiting atherosclerotic progression and stabilizing plaques.
Purpose of the Study:
- To review ultrasonic parameters and sonosensitizers used in SDT for AS.
- To elaborate on the therapeutic effects and mechanisms of SDT in AS.
- To discuss the safety and establish a framework for future SDT research in AS.
Main Methods:
- Review of existing literature on SDT for atherosclerosis.
- Analysis of ultrasonic parameters and sonosensitizers.
- Elaboration on SDT's effects on cellular and molecular components of atherosclerotic plaques.
Main Results:
- SDT demonstrates therapeutic effects on apoptosis and autophagy in AS cells, particularly macrophages.
- SDT influences macrophages, T lymphocytes, neovascularization, smooth muscle cells, lipids, and extracellular matrix within plaques.
- Non-lethal SDT strategies and efferocytosis modulation are discussed.
Conclusions:
- SDT is a promising non-invasive therapy for atherosclerosis, with established effects on plaque components and cellular processes.
- Further research is needed to optimize SDT parameters and sonosensitizers for clinical application in AS.
- This review provides a comprehensive framework for future research into SDT for atherosclerosis.
More Related Videos
09:05Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells
Published on: July 22, 2015
07:51Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System